To fix our current and future problems, it will take all of us pulling together to protect our patients and our specialty. Thank you to all members of the ACR and ARHP who regularly take action on behalf of your patients. To those who have not had the chance to do so in the past, I welcome and encourage your involvement in advocacy in whatever way works best for you. Visit www.rheumatology.org/advocacy to get started.
You Might Also Like
- American College of Rheumatology (ACR) Advocates for Improved Access to Critical Treatments
- ACR Advances Legislation to Increase Patients’ Access to Biologic Drugs to Treat Rheumatoid Arthritis and Other Conditions
- Active Advocacy in the Sunshine State: Florida Society Presses for Legislative Changes to Protect Patient Access to Medications
Explore This IssueFebruary 2018
Also By This Author
All of our individual contributions add up, and together we can make a difference.
David Daikh, MD, PhD, is the 81st president of the ACR. Dr. Daikh serves as the director of the Rheumatology Fellowship Training Program at the University of California, San Francisco and as chief of the Rheumatology Division at the SFVA Medical Center, where he directs the Rheumatology Clinic.
Editor’s note: Congress responded to this ACR advocacy campaign by including a fix to the Part B rule in a continuing resolution. As we go to press, it was being considered for passage. The ACR thanks members who contacted lawmakers, helping make this happen.